Medical Qualifications

Dr Nigel Hacking qualified in Radiology from Southampton University Hospital and went on to complete specialist training at the Middlesex and St Mary's hospitals, London and has worked extensively in the fields of Hepatobiliary, Pancreatic and Gynaecological diagnostic and interventional radiology since 1987.

Medical Experience

Dr Hacking was appointed as a Consultant in Interventional and Abdominal Radiology at Southampton University Hospitals in 1991 and has since specialised in Uterine Fibroid Embolisation (UFE), non-vascular interventional radiology, Trans Arterial Chemo Embolisation (TACE) for liver cancers as well as embolisation for a variety of tumours and metastases.

Dr Hacking has gained one of the most extensive experiences in UFE in the world and has been performing the procedure since 1998. In 2004 he founded Fibroid Caribbean Ltd to coordinate UFE throughout the Caribbean region and offer advice to Caribbean women living at home or overseas. He regularly presents his findings at conferences throughout the world and is widely published, alongside his work in training Consultants in UFE. In 2012 Dr Hacking was responsible for bringing Prostate Artery Embolisation (PAE) to the UK, an innovative treatment for benign prostate hyperplasia/hypertrophy (BPH).

Dr Hacking has pioneered all the latest advances in Obstetric, Gynaecological, Liver, Biliary and Pancreatic and Oncological Interventional Radiology since that time.

Articles written by Dr Nigel Hacking

Deposition on Prostate Artery Embolisation (PAE)

Urination became quite normal in regularity and with some ”force”, as it remains at the time of writing this resumé. A further MRI scan, in May 2020, showed my prostate to have a volume of 94 mls (less than half the size of 9 months previously). In my opinion PAE is quite definitely a better option than surgery if it is considered clinically advisable.

The benefits of prostate artery embolisation as a treatment for benign prostatic hyperplasia or enlarged prostate 

When set alongside TURP then PAE is seen by many as a better option. The procedure is carried out using local anaesthetic and can usually be done as a day case. It involves an interventional radiologist inserting a small catheter into an artery in the upper thigh or wrist using x-ray guidance.

Treating Benign Prostatic Hyperplasia (BPH) by PAE

Introduction to Benign Prostatic Hyperplasia (Enlargement) or BPH / BPE and treatment options What is benign prostatic hyperplasia / benign prostate enlargement (BPH /BPE)? What are the symptoms of BPH / BPE? What are the treatment options for BPH / BPE? What is Prostate Artery Embolisation (PAE)? PAE from research to treatment UK specialist centres Results from the UK-ROPE study For a private PAE referral

Treating enlarged prostate (BPH) by prostate artery embolisation

Benign prostatic hyperplasia/hypertrophy (BPH), an increase in the size of the prostate, is one of the most common causes of Lower Urinary Tract Symptoms (LUTS) affecting men. The process by which the prostate begins enlarging begins around the age of 30 and up to 50% of men will have histological evidence of BPH by 50 years of age. By 80 years of age this rises to 75%, although not all of these men will have symptoms. This article presents an overview of a new and emerging treatment for benign prostatic hyperplasia/hypertrophy known as Prostate Artery Embolisation. 

What is involved in Uterine Fibroid Embolisation (UFE)?

Uterine Fibroid Embolisation (UFE) is a non-surgical, minimally-invasive, procedure that blocks off the arteries that supply the fibroids with blood (the uterine arteries), therefore shrinking the fibroids. It is performed by an interventional radiologist with the patient sedated